<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01112150</url>
  </required_header>
  <id_info>
    <org_study_id>0063-09-HYMC-CTIL</org_study_id>
    <nct_id>NCT01112150</nct_id>
  </id_info>
  <brief_title>Effect of Normatec Pump for Relief of Leg Edema</brief_title>
  <official_title>Effect of Normatec Pump for Relief of Leg Edema: Short- Intermediate- and Longer-term Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that leg edema will decrease rapidly when using the NormaTec
      pump, patients will lose weight, will feel better, will be less prone to infections in their
      legs and to congestion of the liver. Temporary elevation of intravascular fluid volume by the
      mobilized edema fluid returned to the intravascular space by pumping may increase cardiac
      output and renal perfusion and in addition it may distend the right atrium and ventricle thus
      inducing BNP secretion. Both mechanisms may promote excess fluid removal by the kidneys.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>5 days</time_frame>
    <description>The weight loss during the pumping pariod is related to fluid loss from edematous legs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leg circumference</measure>
    <time_frame>5 Days</time_frame>
    <description>The leg circumference will be measured before and after each pumping session to determine the effectiveness of the pumping.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Edema</condition>
  <condition>Heart Failure</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Pumping group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will get a pumping session 2-3 times a day .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No pumping</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients will not receive pumping but only classical treatment clinically indicated (diuretics, oxygen, Digoxin, Nitrates, ACE inhibitors etc, as necessary)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NormaTec Pump</intervention_name>
    <description>Normatec Pump</description>
    <arm_group_label>Pumping group</arm_group_label>
    <arm_group_label>No pumping</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hemodynamically stable adult patients with pronounced leg edema from any etiology, on
             optimal medical therapy (such as diuretics, ACE-I or ARBs, digoxin).

          -  documentation of right heart failure by Echo or other modality (CT, MRI, right heart
             catheterization) and hemodynamic data from Echo is required and an elevated pulmonary
             artery pressure (&gt; 35 mmHg) is expected in such cases.

        Exclusion Criteria:

          -  patients in sepsis,

          -  hemodynamically unstable,

          -  during an acute attack of pulmonary edema,

          -  with renal failure (creatinine &gt; 2 mg%),

          -  with DVT,

          -  psychiatric or noncompliant patients, and

          -  patients who will not sign the informed consent form will be excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David S. Blondheim, MD</last_name>
    <phone>97246304488</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Hille Yaffe Medical Ceter</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David S Blondheim, MD</last_name>
      <phone>97246304488</phone>
    </contact>
    <investigator>
      <last_name>David S. Blondheim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2010</study_first_submitted>
  <study_first_submitted_qc>April 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2010</study_first_posted>
  <last_update_submitted>April 27, 2010</last_update_submitted>
  <last_update_submitted_qc>April 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>David S. Blondheim</name_title>
    <organization>Hillel Yaffe Medical Center</organization>
  </responsible_party>
  <keyword>Edema</keyword>
  <keyword>Heart failure</keyword>
  <keyword>Pulmonary hypertension</keyword>
  <keyword>Edema in legs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Edema</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

